Arcadia Biosciences, Inc.
For the period ended Sep 10, 2026. Filed Sep 15, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Sep 10, 2026 · Filed Sep 15, 2026
Use the contents to explore the available documents and sections.
Contents
PROPOSAL IV: Reverse Stock Split
The Company’s stockholders approved an amendment to the Company’s amended and restated certificate of incorporation to effect a reverse stock split of the Company’s outstanding shares of common stock, if the Board in its discretion determines to effect a reverse stock split at any time before June 30, 2027, at a reverse stock split ratio ranging from 1-for-2 to 1-for-10, as determined by the Board at a later date, by the votes set forth in the table below:
| FOR | AGAINST | ABSTAIN | BROKER NON-VOTES |
|---|---|---|---|
| 1,120,937 | 138,084 | 294 | 0 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.